NHS approves first drug that can delay type 1 diabetes
Teplizumab becomes the first NHS-approved treatment shown to delay the onset of type 1 diabetes. Given as a 14-day course of infusions...
Stories, guides and sensor tips
LIBRE LIFE LATEST NEWS
Articles
-
Latest story
Kickback against CGM? Lancet questions wider adoption
· Samantha Hooper
A newly published correspondence in The Lancet Diabetes & Endocrinology has now reopened a debate that many healthcare systems believed had largely been settled: does wider CGM adoption always represent good value?
Read article -
